In the present study, three approaches of DBD-CAP driven by the advantageous nanosecond pulsed discharge have been applied in breast cancer cells of different morphological and molecular features; the non-metastatic MCF-7/ER+ cells and the metastatic MDA-MB-231/ER- and Hs578T/ER- cells. Here, ESR1 is linked to breast cancer.